Schmitt Walter
Clinical Science, Bayer Pharma AG, Wuppertal, Germany.
Pharm Res. 2017 Jan;34(1):49-57. doi: 10.1007/s11095-016-2037-7. Epub 2016 Sep 14.
To develop an alternative method for estimating vitreal half-lifes in the rabbit eye based on simple equations for the physical processes of dissipation and the physiochemical properties of therapeutic substances applied by intravitreal drug administration.
Equations were derived to describe diffusion in the vitreous humor and permeation through the back-of-the-eye tissue, and the volume of distribution. The model was validated using reported half-life values from 83 compounds collected from literature.
The rate limiting step for dissipation from the vitreous depends mainly on the molecular weight. Dissipation of very low molecular weight (MW) substances (<350 Da) is limited by diffusional transport to the back of the eye, for substances with a MW >350 Da uptake into the back of the eye tissue becomes limiting, and large molecules >500 Da predominantly take an alternative path being cleared through the front of the eye for which diffusion towards the posterior chamber turns out to be limiting. Taking the three rate determining processes into account, the derived model can estimate dissipation rates and respectively vitreal half-life values of small compounds and macromolecules from their molecular weight with very few exceptions.
The equations derived in this analysis provide a simple method to predict vitreal half-lifes for a diverse group of molecules and can be easily implemented in early drug development.
基于药物玻璃体内给药后消散的物理过程及治疗物质的理化性质的简单方程,开发一种估算兔眼玻璃体内半衰期的替代方法。
推导方程以描述玻璃体内的扩散、透过眼后组织的渗透以及分布容积。使用从文献中收集的83种化合物的报告半衰期值对模型进行验证。
玻璃体内消散的限速步骤主要取决于分子量。极低分子量(MW)物质(<350 Da)的消散受扩散至眼后的传输限制,对于MW>350 Da的物质,其进入眼后组织成为限制因素,而大于500 Da的大分子主要通过眼前部清除,其中向后房的扩散成为限制因素。考虑到这三个速率决定过程,所推导的模型能够从分子量估算小分子化合物和大分子的消散速率及玻璃体内半衰期值,仅有极少数例外情况。
本分析中推导的方程提供了一种简单方法来预测不同分子组的玻璃体内半衰期,并且能够在药物早期研发中轻松实施。